Log in

CASI Pharmaceuticals News Headlines (NASDAQ:CASI)

$3.62
+0.34 (+10.37 %)
(As of 10/22/2019 02:11 AM ET)
Today's Range
$3.20
Now: $3.62
$3.67
50-Day Range
$2.98
MA: $3.30
$3.56
52-Week Range
$2.73
Now: $3.62
$5.20
Volume311,613 shs
Average Volume185,111 shs
Market Capitalization$346.50 million
P/E RatioN/A
Dividend YieldN/A
Beta1.12

Headlines

CASI Pharmaceuticals (NASDAQ CASI) News Headlines

Source:
DateHeadline
Reviewing Tcr2 Therapeutics (NASDAQ:TCRR) & CASI Pharmaceuticals (NASDAQ:CASI)Reviewing Tcr2 Therapeutics (NASDAQ:TCRR) & CASI Pharmaceuticals (NASDAQ:CASI)
www.americanbankingnews.com - October 2 at 4:39 PM
CASI Pharmaceuticals Announces The Promotion Of Larry Zhang To PresidentCASI Pharmaceuticals Announces The Promotion Of Larry Zhang To President
finance.yahoo.com - September 19 at 10:31 AM
China NMPA Accepts Clinical Trial Application For CASIs CD19 CAR-T-ProductChina NMPA Accepts Clinical Trial Application For CASI's CD19 CAR-T-Product
finance.yahoo.com - September 18 at 8:08 AM
CASI Pharmaceuticals, Inc. To Present At The 2019 H.C. Wainwright 21st Annual Global Investment ConferenceCASI Pharmaceuticals, Inc. To Present At The 2019 H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 3 at 10:42 AM
Casi Pharmaceuticals Inc (CASI) CEO Wei-wu He Bought $64,000 of SharesCasi Pharmaceuticals Inc (CASI) CEO Wei-wu He Bought $64,000 of Shares
finance.yahoo.com - August 20 at 11:21 PM
What Kind Of Shareholders Own CASI Pharmaceuticals, Inc. (NASDAQ:CASI)?What Kind Of Shareholders Own CASI Pharmaceuticals, Inc. (NASDAQ:CASI)?
finance.yahoo.com - August 19 at 6:08 PM
CASI: CASI launches Evomela - first commercial productCASI: CASI launches Evomela - first commercial product
finance.yahoo.com - August 16 at 6:17 PM
Casi Pharmaceuticals Inc (CASI) CEO Wei-wu He Bought $507,200 of SharesCasi Pharmaceuticals Inc (CASI) CEO Wei-wu He Bought $507,200 of Shares
finance.yahoo.com - August 15 at 10:51 PM
CASI Pharma launches EVOMELA in ChinaCASI Pharma launches EVOMELA in China
seekingalpha.com - August 12 at 9:23 AM
CASI Pharmaceuticals Announces Launch of EVOMELA® (melphalan for injection) in ChinaCASI Pharmaceuticals Announces Launch of EVOMELA® (melphalan for injection) in China
finance.yahoo.com - August 12 at 9:23 AM
Angiogenesis Modulators Market: Huge Growth Opportunities and Challenges to Watch in 2019Angiogenesis Modulators Market: Huge Growth Opportunities and Challenges to Watch in 2019
www.marketwatch.com - August 10 at 10:05 AM
Tumor Necrosis Factor Inhibitors Market: Upcoming Key Events & Latest Innovations in the Industry By 2026Tumor Necrosis Factor Inhibitors Market: Upcoming Key Events & Latest Innovations in the Industry By 2026
www.marketwatch.com - August 9 at 6:19 PM
CASI Pharmaceuticals Announces Second Quarter and First Half 2019 Financial and Business ResultsCASI Pharmaceuticals Announces Second Quarter and First Half 2019 Financial and Business Results
finance.yahoo.com - August 9 at 9:07 AM
Ligand (LGND) Stock Down Despite Q2 Earnings & Sales BeatLigand (LGND) Stock Down Despite Q2 Earnings & Sales Beat
finance.yahoo.com - July 31 at 5:23 PM
Tumor Necrosis Factor Alpha Inhibitors Market Top Trends, Key Companies Profiles, Demand, Regional Market Summary, Segments and Outlook to 2023Tumor Necrosis Factor Alpha Inhibitors Market Top Trends, Key Companies Profiles, Demand, Regional Market Summary, Segments and Outlook to 2023
www.marketwatch.com - July 19 at 11:44 AM
CASI in-licenses rights to anti-CD19 T-cell therapy; shares up 5% premarketCASI in-licenses rights to anti-CD19 T-cell therapy; shares up 5% premarket
seekingalpha.com - June 17 at 10:49 AM
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell TherapyCASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
finance.yahoo.com - June 17 at 10:49 AM
CASI Pharmaceuticals To Present At The 2019 BIO International ConventionCASI Pharmaceuticals To Present At The 2019 BIO International Convention
finance.yahoo.com - June 3 at 9:38 AM
CASI: Making headway towards commercializationCASI: Making headway towards commercialization
finance.yahoo.com - May 20 at 1:05 PM
CASI Pharmaceuticals Announces First Quarter 2019 Financial and Business ResultsCASI Pharmaceuticals Announces First Quarter 2019 Financial and Business Results
finance.yahoo.com - May 15 at 9:45 AM
CASI: Initiating coverage – Leveraging pharmaceutical opportunities in China and beyondCASI: Initiating coverage – Leveraging pharmaceutical opportunities in China and beyond
finance.yahoo.com - May 13 at 6:23 PM
Ligand (LGND) Q1 Earnings & Sales Fall Y/Y, Stock DownLigand (LGND) Q1 Earnings & Sales Fall Y/Y, Stock Down
finance.yahoo.com - May 3 at 6:09 PM
CASI in-licences cancer candidate, shares up 5% premarketCASI in-licences cancer candidate, shares up 5% premarket
seekingalpha.com - April 17 at 10:56 AM
CASI Pharmaceuticals In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 Monoclonal Antibody Program From Black Belt TherapeuticsCASI Pharmaceuticals In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 Monoclonal Antibody Program From Black Belt Therapeutics
finance.yahoo.com - April 17 at 10:56 AM
New CEO at CASI PharmaNew CEO at CASI Pharma
seekingalpha.com - April 2 at 12:14 PM
CASI Pharmaceuticals Announces The Appointment Of Wei-Wu He, Ph.D., Executive Chairman, To The Role Of Chief Executive OfficerCASI Pharmaceuticals Announces The Appointment Of Wei-Wu He, Ph.D., Executive Chairman, To The Role Of Chief Executive Officer
finance.yahoo.com - April 2 at 12:14 PM
CASI PHARMACEUTICALS, INC. CASI Files An 8-K Results of Operations and Financial ConditionCASI PHARMACEUTICALS, INC. CASI Files An 8-K Results of Operations and Financial Condition
www.marketwatch.com - March 29 at 9:55 AM
CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2018 Financial Results And Business ResultsCASI Pharmaceuticals Announces Fourth Quarter And Full Year 2018 Financial Results And Business Results
finance.yahoo.com - March 29 at 9:55 AM
CASI Pharmaceuticals, Inc. Estimate MomentumCASI Pharmaceuticals, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 6:19 PM
CASI Pharma establishes Evomela distribution in ChinaCASI Pharma establishes Evomela distribution in China
seekingalpha.com - March 13 at 8:48 AM
CASI Pharmaceuticals Announces Exclusive Distribution Partner For Melphalan Hydrochloride For Injection (EVOMELA®) In ChinaCASI Pharmaceuticals Announces Exclusive Distribution Partner For Melphalan Hydrochloride For Injection (EVOMELA®) In China
finance.yahoo.com - March 13 at 8:48 AM
CASI Pharma on go to start pivotal study of Marqibo in ChinaCASI Pharma on go to start pivotal study of Marqibo in China
seekingalpha.com - March 7 at 10:30 AM
CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Registration Trial For MARQIBO®CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Registration Trial For MARQIBO®
finance.yahoo.com - March 7 at 10:30 AM
When Will CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Turn A Profit?When Will CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Turn A Profit?
finance.yahoo.com - February 26 at 5:34 PM
CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN® - PRNewswireCASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN® - PRNewswire
www.prnewswire.com - February 19 at 5:44 PM
CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN®CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN®
finance.yahoo.com - February 19 at 10:07 AM
Ligand Reports Fourth Quarter and Full Year 2018 Financial ResultsLigand Reports Fourth Quarter and Full Year 2018 Financial Results
www.marketwatch.com - February 7 at 5:23 PM
Do Institutions Own Shares In CASI Pharmaceuticals, Inc. (NASDAQ:CASI)?Do Institutions Own Shares In CASI Pharmaceuticals, Inc. (NASDAQ:CASI)?
finance.yahoo.com - December 26 at 4:33 PM
Form 8-K CASI Pharmaceuticals, For: Dec 03 - StreetInsider.comForm 8-K CASI Pharmaceuticals, For: Dec 03 - StreetInsider.com
www.streetinsider.com - December 8 at 9:22 AM
The 4 Healthcare Stocks To Watch On MondayThe 4 Healthcare Stocks To Watch On Monday
finance.yahoo.com - December 3 at 4:23 PM
CASI Pharmaceuticals EVOMELA approved in ChinaCASI Pharmaceuticals' EVOMELA approved in China
seekingalpha.com - December 3 at 9:40 AM
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®)CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®)
finance.yahoo.com - December 3 at 9:40 AM
CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi, ChinaCASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi, China
finance.yahoo.com - November 16 at 9:17 AM
Form 8-K CASI Pharmaceuticals, For: Nov 14Form 8-K CASI Pharmaceuticals, For: Nov 14
www.streetinsider.com - November 14 at 9:16 AM
CASI Pharmaceuticals Announces Third Quarter and First Nine Months 2018 Financial and Business ResultsCASI Pharmaceuticals Announces Third Quarter and First Nine Months 2018 Financial and Business Results
finance.yahoo.com - November 14 at 9:16 AM
Today’s Research Reports on Stocks to Watch: CASI Pharmaceuticals and Therapix BiosciencesToday’s Research Reports on Stocks to Watch: CASI Pharmaceuticals and Therapix Biosciences
finance.yahoo.com - October 24 at 9:36 AM
CASI Pharmaceuticals acquires HBV ANDA from Laurus LabsCASI Pharmaceuticals acquires HBV ANDA from Laurus Labs
seekingalpha.com - October 23 at 4:15 PM
Why CASI Pharmaceuticals Inc. Is Rocketing Higher TodayWhy CASI Pharmaceuticals Inc. Is Rocketing Higher Today
finance.yahoo.com - October 23 at 4:15 PM
CASI Pharma (CASI) Acquires HBV ANDA from Laurus Labs LimitedCASI Pharma (CASI) Acquires HBV ANDA from Laurus Labs Limited
www.streetinsider.com - October 23 at 9:32 AM
26 Stocks Moving In Thursdays Pre-Market Session26 Stocks Moving In Thursday's Pre-Market Session
www.benzinga.com - October 4 at 4:12 PM
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel